Loading clinical trials...
Loading clinical trials...
Long-term Outcomes of Bariatric Patients Treated With Gastric Bypass or Single-anastomosis Sleeve Ileal Bypass (SASI Bipartition)
The main aim of this project is to assess the safety and efficiency of the SASI Bipartition.
The Roux-en-Y Gastric Bypass (RYGB) is the procedure of choice in morbid obesity with metabolic disorders in most of the reference centers. Recent data describes the SASI Bipartition as being as efficient on weight loss and co-morbidities as the RYGB, with the advantage of being less technically difficult and less morbidity. In order to draw definite conclusions regarding the procedure, larger series with longer follow-up are necessary. Patients with BMI over 40, or with BMI over 35 with comorbidities are offered SASI Bipartition with 300 cm common limb or standard RYGB. Follow up is performed through visits at 3, 12, 24, 36, 48, and 60 months after surgery. Results on weight loss, comorbidities resolution, complications, and need of supplements are registered.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Aleris Hospital
Oslo, Norway
Start Date
August 1, 2020
Primary Completion Date
July 1, 2027
Completion Date
August 1, 2027
Last Updated
February 6, 2025
280
ESTIMATED participants
SASI Bipartition
PROCEDURE
Gastric bypass
PROCEDURE
Lead Sponsor
Aleris Hospital
NCT07237750
NCT07460856
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions